The current valuation score of LifeVantage Corp is 8.83, ranking 76 out of 155 in the Pharmaceuticals industry. Its current P/E ratio is 13.78, which is 535.89% below the recent high of 87.64 and 797.35% above the recent low of -96.11.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.